West, T <br/><br/>
Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other Tauopathies.  [electronic resource] 

 -  The journal of prevention of Alzheimer's disease  2017 
 - 236-241 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>2426-0266 
<br/><br/><label>Standard No.: </label>10.14283/jpad.2017.36  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Double-Blind Method<br/>Drug Evaluation, Preclinical<br/>Humans<br/>Immunologic Factors--adverse effects<br/>Immunotherapy<br/>Models, Biological<br/>Tauopathies--blood